A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

NCT00399230 | Completed Phase 4

• 1 other identifier: 5279
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

Conditions

Dry Eye

Interventions

Optive DRUG

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• · Dry eye disease diagnosis
• Patients must currently be using Systane tears at least once a day and for at least 1 month.
• Normal lid position and closure
• Male or female of legal age of consent
• Informed consent has been obtained
• Likely to complete all required follow-up visits

You may not qualify if:

• · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.
• Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.

Sponsors & Collaborators

• Innovative Medical: lead

Study Sites (1)

Dr. Rajpal

McLean, Virginia, 22102, United States

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus Diseases; Eye Diseases

Study Officials

• Rajesh Rajpal, MD

  See Clearly Vision Group

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: NON RANDOMIZED
• Masking: NONE
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY

Study Record Dates

• First Submitted: November 9, 2006
• First Posted: November 14, 2006
• Last Updated: August 21, 2007

Record last verified: 2007-08

Locations

US (1)